Investor Relations Financials & Filings Financial Fundamentals

NASDAQ IMMY
All financial information contained in this page was current and accurate only as of its respective date, may not have been audited by Imprimis’s independent registered public accounting firm, and represents only a portion of Imprimis’s complete financial statements and related notes, which are contained in the annual and quarterly reports filed with the Securities and Exchange Commission. The abbreviated financial information contained on this page should be read in conjunction with Imprimis’s complete financial statements and their related notes, and you are urged to carefully review and consider the various related disclosures made by in the reports filed with the SEC, which discuss the company’s financial results and business in greater detail.

Select the financial statements you wish to view below.

Stay Connected

Imprimis Pharmaceuticals, Inc.
Investor Relations
12264 El Camino Real, Suite 350
San Diego, CA 92130
T: 858.704.4040 | F: 858.345.1745

Contact Us Today

 

Stay Informed

Interested in receiving investor news and updates?

Click Here


Download Imprimis’ IR App for smart phones and tablets for the latest news, reports, presentations and more.